HAE manifests when Cl-esterase-inhibitor, a naturally occurring molecule, is generated in low or dysfunctional levels.
-
The US Food and Drug Administration approved kalbitor in December 2009. -
HAE manifests when Cl-esterase-inhibitor, a naturally occurring molecule, is... -
HAE, also known as Quincke edema, is a rare heredity disease.
